Academic Affiliation
Research Professor, School of Life Sciences in the College of Liberal Arts and Sciences; and Center Faculty Fellow, Sandra Day O'Connor College of Law
Credentials
PhD, University of Alabama
Bio
Dr. Cardineau began his career in the field of Agricultural Biotechnology in 1983 as a scientist at a small start-up company, Sungene Technologies, where he also served a short time as manager of market development. He moved to Agrigenetics in 1989 as manager and then director of molecular biology. In 1993, Agrigenetics was acquired by Mycogen Corporation, and Dr. Cardineau assumed responsibility as director for the merged Molecular Biology groups and eventually for Biochemistry as well.
In 1996, he became director, technology development, involved in strategic planning and implementation regarding intellectual property and the identification, evaluation and acquisition of technology directed toward future product development. Dow AgroSciences acquired Mycogen in 1998, and Dr. Cardineau returned to research assuming the positions of global leader R&D, output agriculture gene discovery and site leader for the San Diego, CA, Research Facility. In 2002, he became global leader for Science and Technology with responsibilities involved in strategic research planning. His efforts, collectively with members of his research team, have resulted in several agricultural biotechnology products in the market place and in commercial development.
He left DAS in the fall of 2002 and co-founded Center for Infectious Diseases and Vaccinology, with Charles Arntzen, Richard Mahoney and Hugh Mason, as part the Center for Infectious Diseases and Vaccinology of the Biodesign Institute at Arizona State University. As of January 1, 2003 he is a research professor at ASU with appointments in the Biodesign Institute, the School of Life Sciences and the College of Law.